India Today on MSN

An oral pill for snoring to be approved, may change sleep apnea treatment forever

A nightly oral pill for obstructive sleep apnea is close to regulatory approval in the US. This medicine-based option could ...

A 'Holy Grail' Sleep Apnea Pill Could Be On The Market Next Year

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

Incannex Healthcare Wins Research and Development Award for Obstructive Sleep Apnea Program in the 2025 Clinical Trials Arena Excellence Awards

Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today announced that it has been honored with the Research and ...

Inside The J.P. Morgan Healthcare Extravaganza

In this week’s edition of InnovationRx, we look at a ‘holy grail’ pill for sleep apnea, Pomelo Care’s expansion, Nvidia and ...
Victoria Advocate

DeTar introduces new sleep apnea treatment system

DeTar Healthcare System is pleased to announce that the upper airway stimulation system, an advanced treatment option for ...